Data Composite

Drug Recalls

Recent drug recall reports from the FDA (US) and Health Canada, newest first. Each entry links to the full record -- product description, reason for recall, and severity classification -- refreshed daily.

JAMP Temozolomide

Canada Type II Ongoing · initiated 2026-08-31

Product quality. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product, or for any health conce…

Apo-Semaglutide

Canada Type II Ongoing · initiated 2026-08-27

Product quality. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product, or for any health conce…

Semaglutide Injection

Canada Type II Ongoing · initiated 2026-08-26

Product quality. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product, or for any health conce…

Twins Herbal Idakole and Twins Herbal Pelorie

Canada Type I Ongoing · initiated 2026-08-25

Undeclared substance. Discontinue use of the affected products. Consult your healthcare provider for any health concerns.Do not buy or use unauthorized health p…

CISATRACURIUM BESYLATE INJECTION USP MULTIDOSE

Canada Type III Ongoing · initiated 2026-08-19

Product quality. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health co…

Lactated Ringer's Injection USP

Canada Type I Ongoing · initiated 2026-08-17

Product quality. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product, or for any health conce…

Adequan I.M

Canada Type III Ongoing · initiated 2026-08-12

Product quality. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product, or for any health conce…

pms-IRBESARTAN 150 mg Tablet

Canada Type II Ongoing · initiated 2026-08-12

Contamination. Verify whether your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product, or if you have any h…

Semaglutide Injection

Canada Type II Ongoing · initiated 2026-08-11

Packaging. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product, or for any health concerns.Co…

TEVA-ECTOSONE 0.1% Cream

Canada Type II Ongoing · initiated 2026-08-07

Labelling. Verify if your product is affected. If the lot number and expiry date are missing, your product may be affected by this recall.Consult your healthcar…

JAMP Methotrexate 10 mg Tablets

Canada Type II Ongoing · initiated 2026-08-05

Product quality. Verify whether your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product, or if you have any…

Zydus Pharmaceuticals (USA) Inc

US Class II Ongoing · initiated 2026-08-05

CGMP: Due to Out of Specification (OOS) result for N-Nitroso Mirabegron impurity.

Novartis Pharmaceuticals Corporation

US Class II Ongoing · initiated 2026-08-04

Failed Dissolution Specifications

Shoolin Pharma Chem LLP

US Class II Ongoing · initiated 2026-08-03

CGMP Deviations:Noted during FDA inspection

Shoolin Pharma Chem LLP

US Class II Ongoing · initiated 2026-08-03

CGMP Deviations:Noted during FDA inspection

Shoolin Pharma Chem LLP

US Class II Ongoing · initiated 2026-08-03

CGMP Deviations:Noted during FDA inspection

Shoolin Pharma Chem LLP

US Class II Ongoing · initiated 2026-08-03

CGMP Deviations:Noted during FDA inspection

Shoolin Pharma Chem LLP

US Class II Ongoing · initiated 2026-08-03

CGMP Deviations:Noted during FDA inspection

Liebel-Flarsheim Company LLC

US Class I Ongoing · initiated 2026-07-31

Presence of Particulate Matter: comprising polyethylene and other plastic materials, stainless steel and glass.

Femyso Mifepristone 200mg / Misoprostol 200 mcg tablet

Canada Type II Ongoing · initiated 2026-07-30

Packaging. Verify whether your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product, or if you have any healt…

Pharmasave Regular Strength Dairy Digestive Supplement Lactase Enzyme

Canada Unclassified Ongoing · initiated 2026-07-30

Labelling. Verify whether your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product, or for any health concer…

Heritage Pharmaceuticals Inc

US Class II Ongoing · initiated 2026-07-30

Presence of Foreign Substance: presence of particles and white flakes in the reconstituted bottles.

Apollo Care, LLC

US Class II Ongoing · initiated 2026-07-29

Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material

Apollo Care, LLC

US Class II Ongoing · initiated 2026-07-29

Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material

Apollo Care, LLC

US Class II Ongoing · initiated 2026-07-29

Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material